Wolfe Research Initiates Coverage On Janux Therapeutics with Peer Perform Rating
Benzinga Newsdesk 11 months ago
NewsInitiationAnalyst Ratings
Wolfe Research analyst Kalpit Patel initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Peer Perform rating.
Wolfe Research analyst Kalpit Patel initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Peer Perform rating.